“Dexmedetomidine Reduces Ventilator-Induced Lung Injury (VILI) by Inhibiting Toll-Like Receptor 4 (TLR4) Nuclear Factor (NF)-κB Signaling Pathway”. 2018. Biomolecules and Biomedicine 18 (2): 162-69. https://doi.org/10.17305/bjbms.2018.2400.